ProfileGDS4718 / 217214_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 13% 12% 10% 13% 10% 13% 13% 11% 14% 12% 13% 15% 10% 12% 9% 13% 10% 10% 13% 7% 12% 12% 16% 19% 14% 14% 15% 6% 13% 16% 12% 14% 12% 15% 16% 13% 10% 12% 11% 9% 15% 14% 13% 15% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9182213
GSM549102patient 115, normal, homogenized [OPG study]3.8782912
GSM549104patient 119, normal, homogenized [OPG study]3.7512710
GSM549108patient 138, normal, homogenized [OPG study]3.9144813
GSM549119patient 077, normal, homogenized [OPG study]3.7647710
GSM549133patient 032, cancer, homogenized [OPG study]3.8599113
GSM549139patient 042, cancer, homogenized [OPG study]3.8655413
GSM549099patient 107, normal, homogenized [OPG study]3.8426211
GSM549109patient 139, normal, homogenized [OPG study]3.9406314
GSM549110patient 046, normal, homogenized [OPG study]3.8488912
GSM549114patient 063, normal, homogenized [OPG study]3.8571113
GSM549122patient 082, normal, homogenized [OPG study]3.9579915
GSM549134patient 033, cancer, homogenized [OPG study]3.7937810
GSM549136patient 036, cancer, homogenized [OPG study]3.8253112
GSM549140patient 044, cancer, homogenized [OPG study]3.698639
GSM549111patient 047, normal, homogenized [OPG study]3.8861113
GSM549113patient 057, normal, homogenized [OPG study]3.7510710
GSM549132patient 031, cancer, homogenized [OPG study]3.7799510
GSM549137patient 038, cancer, homogenized [OPG study]3.8716713
GSM549142patient 047, cancer, homogenized [OPG study]3.706647
GSM549100patient 110, normal, homogenized [OPG study]3.8455312
GSM549107patient 135, normal, homogenized [OPG study]3.8127912
GSM549115patient 068, normal, homogenized [OPG study]3.9677316
GSM549116patient 072, normal, homogenized [OPG study]4.0984219
GSM549120patient 078, normal, homogenized [OPG study]3.929614
GSM549131patient 030, cancer, homogenized [OPG study]3.8930914
GSM549118patient 074, normal, homogenized [OPG study]3.9497115
GSM549129patient 027, cancer, homogenized [OPG study]3.652096
GSM549123patient 088, normal, homogenized [OPG study]3.8995413
GSM549124patient 006, cancer, homogenized [OPG study]4.0436716
GSM549126patient 015, cancer, homogenized [OPG study]3.8314912
GSM549128patient 025, cancer, homogenized [OPG study]3.912614
GSM549103patient 117, normal, homogenized [OPG study]3.8825212
GSM549117patient 073, normal, homogenized [OPG study]3.9652515
GSM549138patient 041, cancer, homogenized [OPG study]3.9897216
GSM549141patient 045, cancer, homogenized [OPG study]3.8268513
GSM549130patient 028, cancer, homogenized [OPG study]3.8012110
GSM549101patient 111, normal, homogenized [OPG study]3.8493412
GSM549105patient 128, normal, homogenized [OPG study]3.815511
GSM549106patient 134, normal, homogenized [OPG study]3.709019
GSM549112patient 048, normal, homogenized [OPG study]3.9490315
GSM549125patient 011, cancer, homogenized [OPG study]3.9537214
GSM549127patient 024, cancer, homogenized [OPG study]3.8509213
GSM549135patient 035, cancer, homogenized [OPG study]3.9011215